Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noncoding RNAs in Alzheimer's disease.

M Laura Idda1, Rachel Munk1, Kotb Abdelmohsen1

  • 1Laboratory of Genetics and Genomics, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland.

Wiley Interdisciplinary Reviews. RNA
|January 13, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types.

Molecular cell·2026
Same author

Characterization of the m<sup>6</sup>A Epitranscriptome in Fibroblast Senescence.

Molecular and cellular biology·2026
Same author

Toward actionable interventions in human aging (12th ARDD meeting, 2025).

Aging·2026
Same author

SenCat: Cataloging human cell senescence through multiomic profiling of multiple senescent primary cell types.

bioRxiv : the preprint server for biology·2026
Same author

The Secretome of Human Trophoblast Stem Cells Attenuates Senescence-Associated Traits.

Aging cell·2026
Same author

GRSF1 loss in THP-1 macrophages promotes senescence-associated transcription in neighboring fibroblasts.

Scientific reports·2025

Noncoding RNAs (ncRNAs) are increasingly recognized for their role in Alzheimer's disease (AD) pathogenesis. Targeting these regulatory ncRNAs offers a promising therapeutic strategy for combating AD pathology and dementia.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia, characterized by amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) due to hyperphosphorylated Tau.
  • Current therapeutic strategies for AD have limited efficacy, highlighting the need for novel treatment approaches.
  • The full spectrum of molecular factors contributing to AD pathogenesis remains incompletely understood.

Purpose of the Study:

  • To review the role of noncoding RNAs (ncRNAs) in Alzheimer's disease.
  • To discuss the posttranscriptional regulation of key AD pathways by ncRNAs.
  • To explore the therapeutic potential of targeting ncRNAs in AD.

Main Methods:

  • Literature review of studies investigating ncRNAs in Alzheimer's disease.
Keywords:
amyloid plaquescircRNAlncRNAmiRNAneurodegenerationneurofibrillary tanglesnoncoding RNAposttranscriptional gene regulation

Related Experiment Videos

  • Analysis of ncRNA involvement in major AD-related molecular pathways.
  • Discussion of ncRNA-based therapeutic strategies.

    • Main Results:

    • Noncoding RNAs, including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), are implicated in AD onset and progression.
    • ncRNAs regulate gene expression at transcriptional and posttranscriptional levels, influencing AD pathology.
    • ncRNAs serve as potential biomarkers and therapeutic targets for AD.

    Conclusions:

    • ncRNAs play a significant role in the pathogenesis of Alzheimer's disease.
    • Targeting regulatory ncRNAs presents a promising avenue for developing novel AD therapies.
    • Further research into ncRNA mechanisms could lead to effective treatments for AD and dementia.